News Releases

Less Is More: New Treatment Protocol for MDS and AML Is as Effective But Less Toxic than Standard Care
Montefiore Einstein Cancer Center Awarded $2.9M NCI Calabresi Training Award
Einstein Celebrates Its 65th Commencement

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Clinical and Research Centers

Expert List for Media

Sanjeev Gupta

Sanjeev Gupta, M.B.,B.S., M.D.

Area(s) of expertise: Stem cell researchCell therapyGene therapy

Dr. Gupta is a pioneer in the development of cell therapy – treating disease by introducing healthy cells into the body.  He has discovered various mechanisms for coaxing transplanted cells to attach to host tissue… Learn more

Einstein in the News

Science News
Four Things to Know About Malaria Cases in the United States

Johanna Daily, M.D., M.S., discusses the current outbreak of malaria in Texas and Florida and says the risk of transmission is low and the disease is preventable and curable. Dr. Daily is professor of medicine and of microbiology & immunology at Einstein and an infectious disease physician at Montefiore.

Additional coverage includes Fox News and WIRED

More coverage on Dr. Daily

Diabetes Will Be ‘A Defining Disease of This Century’ As Global Cases Are Set to Surpass One Billion by 2050

Shivani Agarwal, M.D., M.P.H., discusses a series in The Lancet, which she led, that described the exponential growth of diabetes globally, driven by structural racism and geographic inequities, and outlines action plans to address the issue. Dr. Agarwal is associate professor of medicine and associate director of the Fleischer Institute for Diabetes and Metabolism at Einstein and an endocrinologist at Montefiore.

Additional coverage includes The Mirror, The Guardian, Independent, Al Jazeera, and CNN Brazil (requires translation) and New York Post

New York Social Diary
In the Spirit of Achievement

Marla Keller, M.D., was among the honorees at the 68th Spirit of Achievement Awards Luncheon hosted by the Women's Division of Albert Einstein College of Medicine. Dr. Keller is director of the Harold and Muriel Block Institute for Clinical and Translational Research, and professor and vice chair of medicine at Einstein and Montefiore.

More coverage on Dr. Keller


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos